newsfilter
← Latest News
GlobeNewswire·

Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons

  • Genmab A/S disclosed transactions made by managerial employees & their closely associated persons in accordance with EU Market Abuse Regulation.
  • The company holds power of attorney to publish these trading details on behalf of the relevant individuals.
  • Genmab is an international biotechnology firm headquartered in Copenhagen, Denmark, established in 1999.
  • The company has 25 years of experience developing antibody-based therapeutics, including bispecific antibodies & antibody-drug conjugates.
  • Genmab currently powers eight approved antibody medicines & maintains a late-stage clinical pipeline.
  • The announcement includes forward-looking statements regarding future results, clinical trials, & product development risks.
  • Genmab A/S trademarks include Genmab, HuMax, DuoBody, HexaBody, DuoHexaBody, HexElect, & KYSO.
  • Contact for inquiries includes Marisol Peron (SVP, Global Communications & Corporate Affairs) & Andrew Carlsen (VP, Head of Investor Relations).
Company
Genmab A/S
Keywords
Copenhagen Stock Exchange:GMAB, Genmab A/S